AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2019
Mar 1, 2019
29875_dirs_2019-03-01_c9b6d567-61a9-4d9a-b786-9e768676b157.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2019-02-28
Reporting Person: Moriarty Thomas M (EVP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-28 | Common Stock | A | 10869 | $57.83 | Acquired | 38306.0221 | Direct |
| 2019-02-28 | Common Stock | F | 6120 | $57.83 | Disposed | 32186.0221 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 34270 | Direct |
| Stock Unit | 42631.5037 | Direct |
Footnotes
F1: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.
F2: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3